4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-020814
Chief Technology Officer sold 20,000 shares at $11.64 ($232,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-03-21 | Sale | −20,000 | $11.64 | $232,800 | 8,142,803 | D |
| Open-market sales · 20,000 sh · avg $11.64 · $232,800 | |||||||
Loading xslF345X03/doc4.xml…